Why Embedding Diversity Matters

Redefining Access: Embedding Diversity into the Clinical Research Ecosystem

David Alvaro of Pharma’s Almanac recently sat down with Javara’s Tegan Mead, Executive Director, Healthcare Alliance for a two part interview to discuss some of today’s hot topics. In a politically charged, rapidly evolving clinical research ecosystem, there was much to talk about on the theme of diversity and representation. Things like how…

🔸Clinical research without diversity isn’t just unethical, it’s scientifically flawed
🔸Trust isn’t built in a brochure, it’s earned by showing up, again and again and again
🔸An integrated model means being able to bring research to patients, and meet them right where they are
🔸Diverse teams on the ground drive trust, access and inclusion where it counts

“Diversity in trials isn’t just an ethical imperative — it’s essential to ensure that investigational drugs are safe and effective for the full range of people who may use them. It is also imperative to population health and quality of care for underrepresented minorities.”

Read the full interview with Pharma’s Almanac!